COMMUNIQUÉS West-GlobeNewswire

BioStem Technologies (BSEM) Subsidiary Nesvik Pharmaceuticals Announces the Completion of An Asset Purchase of Multiple New Drug Compounds and Launches Joint Development Venture with CCM Pharma Solutions

19/07/2018 - 15:00

Pompano Beach, FL, July 19, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals (f/k/a BioStem Pharmaceuticals), a subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life [...]

Oncobiologics Completes Exchange of Series A Convertible Preferred Stock for Newly Created Series A-1 Convertible Preferred Stock

19/07/2018 - 15:00

CRANBURY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (Nasdaq:ONS) today announced that, on July 18, 2018, the Company completed the exchange of an aggregate of 58,735 shares of voting Series A [...]

Harvard Bioscience Schedules Second Quarter 2018 Conference Call for July 26 at 4:30 PM ET

19/07/2018 - 15:00

HOLLISTON, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for [...]

Golden Leaf Holdings Provides Progress Update for Medical Marijuana Group

19/07/2018 - 15:00

Canadian subsidiary secures first cannabis harvest and submits application to Health Canada for final sales license inspection TORONTO, July 19, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “ [...]

Devonian Health Group announces Non-Brokered Financing by way of a private placement of Convertible Debenture

19/07/2018 - 14:45

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. Aspri Pharma Canada Inc. acts as lead subscriber Unsecured Convertible Debentures convertible at a price of $0.75 Interest at a [...]

Groupe Santé Devonian annonce un financement privé, sans syndicat de courtiers, de débentures convertibles

19/07/2018 - 14:45

NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS Aspri Pharma Canada Inc. agit en tant que souscripteur principal Débentures convertibles non garanties convertibles au prix de 0,75 $ [...]

International Endeavors Corp. (IDVV) Reports Canadian Interest is Greater than Expected

19/07/2018 - 14:30

TEMECULA, Calif., July 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC stock symbol: IDVV) manufacturer the Off-Grid Grow Laboratory (OGGL) for licensed marijuana growers, [...]

Galen Partners completes investment in SMP Pharmacy Solutions, a niche-focused, high-touch specialty pharmacy

19/07/2018 - 14:30

Galen teams with SMP’s Founder / CEO and existing management to recapitalize the company STAMFORD, Conn., July 19, 2018 (GLOBE NEWSWIRE) -- Galen Partners, a healthcare-focused growth equity investment firm, announced [...]

Interpace Diagnostics Expands Application of Pancreatic Cancer Test

19/07/2018 - 14:30

PancraGEN® Gaining Further Guideline Support and Expanded Use for Multiple New Indications PARSIPPANY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace [...]

MPX Enters Into Extraction Agreement With Southern California’s Largest Cannabis Processing Facility, Case Farms Collective

19/07/2018 - 14:30

Relationship will provide a full scale operation of services to MPX’s proprietary specifications and guidelines, establishing the Company’s footprint in California TORONTO, July 19, 2018 (GLOBE NEWSWIRE) -- MPX [...]

Arbutus to Report Second Quarter 2018 Financial Results

19/07/2018 - 14:30

WARMINSTER, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its second [...]

Mustang Bio Completes Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)

19/07/2018 - 14:30

IND filing for MB-102 in BPDCN, AML and high-risk myelodysplastic syndrome on track for Q4 2018 NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) [...]

Trinity Biotech Announces Results for Q2, 2018

19/07/2018 - 14:25

DUBLIN, Ireland, July 19, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced [...]

GTX Corp Engages Doost, Inc. to Open Retail Channels

19/07/2018 - 14:14

LOS ANGELES, July 19, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, today announces the [...]

Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results

19/07/2018 - 14:05

SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 9, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]

Poseida Therapeutics Appoints John P. Schmid to Board of Directors

19/07/2018 - 14:00

SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. , a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced the appointment [...]

Chembio Diagnostics Appoints Christine Rousseau, Ph.D. as Vice President, Corporate Development

19/07/2018 - 14:00

MEDFORD, N.Y., July 19, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced the appointment of Christine M. Rousseau, Ph.D. as Vice [...]

Women In Bio Announces Completion of the 2018 Boardroom Ready Selection Process

19/07/2018 - 14:00

NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, is pleased to announce [...]

Progressive Care Signs Two New 340B Contracts to Bring Discounted Prescription Programs to Non-Profit Healthcare Institutions

19/07/2018 - 14:00

MIAMI, July 19, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that they have signed two new 340B contracts, furthering their [...]